Payden & Rygel’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$206K Sell
5,110
-282,200
-98% -$12.6M 0.02% 107
2026
Q2
$13.4M Hold
287,310
– – 1.03% 49
2026
Q1
$14.1M Hold
287,310
– – 1.08% 39
2025
Q4
$12.5M Sell
287,310
-118,600
-29% -$5.41M 0.87% 43
2025
Q3
$18.3M Buy
405,910
+150,800
+59% +$6.62M 1.52% 25
2025
Q2
$11.1M Buy
255,110
+250,000
+4,892% +$11.1M 0.92% 53
2025
Q1
$235K Hold
5,110
– – 0.02% 106
2024
Q4
$192K Hold
5,110
– – 0.02% 107
2024
Q3
$207K Hold
5,110
– – 0.02% 109
2024
Q2
$177K Hold
5,110
– – 0.01% 108
2024
Q1
$192K Sell
5,110
-252,100
-98% -$9.01M 0.01% 121
2023
Q4
$9.23M Sell
257,210
-145,100
-36% -$5.59M 0.64% 72
2023
Q3
$15.2M Sell
402,310
-8,300
-2% -$338K 1.04% 35
2023
Q2
$16.7M Buy
410,610
+73,000
+22% +$3.02M 1.18% 34
2023
Q1
$14.1M Buy
337,610
+195,810
+138% +$8.16M 0.84% 59
2022
Q4
$6.13M Sell
141,800
-648,100
-82% -$25.6M 0.33% 73
2022
Q3
$29.6M Buy
789,900
+13,400
+2% +$592K 1.73% 17
2022
Q2
$35.2M Buy
776,500
+270,200
+53% +$12.7M 2.11% 11
2022
Q1
$24.1M Buy
+506,300
New +$21.4M 1.22% 33
2015
Q3
– Sell
-547
Closed -$12K – 147
2015
Q2
$12K Hold
547
– – ﹤0.01% 170
2015
Q1
$13K Hold
547
– – ﹤0.01% 178
2014
Q4
$14K Hold
547
– – ﹤0.01% 173
2014
Q3
$13K Hold
547
– – ﹤0.01% 174
2014
Q2
$14K Hold
547
– – ﹤0.01% 188
2014
Q1
$13K Buy
547
+407
+291% +$8.57K 0.01% 182
2013
Q4
$3K Hold
140
– – ﹤0.01% 240
2013
Q3
$3K Hold
140
– – ﹤0.01% 225
2013
Q2
$3K Buy
+140
New +$3.4K ﹤0.01% 220

Other funds holding EXC

Payden & Rygel's EXC Position: Q3 2026 in Review

Payden & Rygel reduced its Exelon (EXC) stake by 98% in Q3 2026, selling an estimated $12.6M and leaving 5,110 shares worth $206K. The position accounts for 0.02% of the portfolio, ranked #107.

Payden & Rygel first reported a position in EXC in Q2 2013 and has held it in 28 quarters since. The position peaked at $35.2M in Q2 2022. 532 funds tracked by Wall St. Rank hold EXC as of Q3 2026.

  • Payden & Rygel held 5,110 shares of Exelon worth $206K as of Q3 2026.
  • Payden & Rygel sold 282,200 Exelon shares in Q3 2026, an estimated $12.6M.
  • Exelon made up 0.02% of Payden & Rygel's portfolio in Q3 2026, its #107 holding.
  • Payden & Rygel first reported a position in Exelon in Q2 2013 and has held it in 28 quarters since.
  • Payden & Rygel's Exelon position peaked at $35.2M in Q2 2022.
  • 532 funds tracked by Wall St. Rank held Exelon as of Q3 2026.

Based on Payden & Rygel's 13F filing for Q3 2026, filed 28 Oct 2026.